A novel bioactive porous CaSiO3 scaffold for bone tissue engineering.

Developing scaffolds that support bone regeneration remains a challenge in tissue engineering. Prior research has shown that calcium silicate (CaSiO3) materials can promote bone formation. However, few studies have examined the bioactivity and degradation of porous CaSiO3 scaffolds. This gap motivated the investigation of a novel porous CaSiO3 scaffold. No prior work had resolved the effects of such scaffolds on cell proliferation and differentiation. The need for biodegradable, bioactive scaffolds with interconnected pores is well established. This paper contributes by testing a new fabrication method. The study focuses on whether these scaffolds can support osteoblast-like cell behavior. The findings aim to inform the design of scaffolds for bone tissue engineering.

This study aimed to fabricate and evaluate a novel porous CaSiO3 scaffold for bone tissue engineering. The primary objective was to assess the scaffold's bioactivity and its ability to support osteoblast-like cell proliferation and differentiation. The researchers proposed that the scaffold's porosity and composition could influence cell behavior. They sought to determine if the scaffold could form a hydroxyapatite layer in simulated body fluid. The study also aimed to evaluate the scaffold's degradation rate in Ringer’s solution. They hypothesized that the interconnected pores would enhance cell adhesion and growth. The design focused on whether the scaffold could serve as a suitable substrate for bone regeneration. The results could guide future scaffold development for clinical applications.

The researchers fabricated the scaffolds using a ceramic slip-coated polymer foam. The foam was sintered at 1350 degrees Celsius to produce CaSiO3 scaffolds. X-ray diffraction confirmed the phase purity of the material as alpha-CaSiO3. Scanning electron microscopy assessed the scaffold's porous structure and surface morphology. Energy-dispersive spectroscopy analyzed elemental composition after soaking in simulated body fluid. Weight loss measurements in Ringer’s solution evaluated in vitro degradation. Osteoblast-like cells were seeded onto the scaffolds to study cell behavior. SEM and biochemical assays assessed cell adhesion, proliferation, and alkaline phosphatase activity.

The scaffolds exhibited a well-interconnected porous structure with pore sizes ranging from micrometers to over 100 micrometers. Porosity averaged 88.5% ± 2.8%, indicating high structural openness. XRD confirmed the material was primarily alpha-CaSiO3. SEM and EDS analysis showed hydroxyapatite formation on the scaffold surface after soaking in simulated body fluid. Weight loss measurements indicated that the scaffolds were degradable in Ringer’s solution at 37 degrees Celsius. Cell seeding experiments revealed significant cell adhesion and spreading within the scaffolds. Proliferation rates and alkaline phosphatase activity were higher in scaffold samples compared to controls. These findings suggest the scaffolds support osteoblast-like cell growth and differentiation.

The study demonstrated that the fabricated CaSiO3 scaffolds have a suitable porous structure for bone tissue engineering. The scaffolds exhibited bioactivity, as evidenced by hydroxyapatite formation in simulated body fluid. The interconnected pores and high porosity may enhance cell infiltration and nutrient transport. The scaffolds supported osteoblast-like cell adhesion and proliferation. Alkaline phosphatase activity indicated potential for cell differentiation. Degradation in Ringer’s solution suggests the material is biodegradable. The findings suggest the scaffolds have initial in vitro cell compatibility. These results support their potential use in bone tissue engineering applications.